| 【Company Research】Mengniu Dairy (2319 HK) – A laggard play to this early-staged consumption-led recovery |
| 【Sector Research】China Property Sector – Mildly positive for CSRC’s pilot private investment scheme in real estate |
| 【Company Research】Tencent (700 HK) – What next to look forward to? |
| 【Company Research】InnoCare Pharma (9969 HK) – Breakup with Biogen on orelabrutinib for the treatment of autoimmune diseases |
| 【Company Research】Pinduoduo (PDD US) – Resilient GMV growth to sustain in 2023 |
| 【Company Research】Xiabu Xiabu Catering (520 HK) – Much needed reforms to bring XBXB nationwide |
| 【Company Research】AK Medical (1789 HK) – Accelerating import substitution; positive outlook of 2023E |
| 【Company Research】Yancoal Australia (3668 HK) – Confirmation of price cap and volume to remove overhang |
| 【Fixed Income Research】HK corps: Perps offer better value than seniors |
| 【Sector Research】China Property Sector – Good news is bad news? |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
